| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |